Professor & Director, PRIME Institute
University of Minnesota
PRIME Institute, College of Pharmacy, University of Minnesota
Minneapolis, MN, United States
Dr. Schondelmeyer is Professor and Endowed Chair in Pharmaceutical Management & Economics at the University of Minnesota. He is Director of the PRIME Institute and its Resilient Drug Supply Project. His expertise includes mapping the upstream drug supply chain to improve resilience and prevent drug shortages, pricing patterns of the pharmaceutical industry, pharmacoeconomics and outcomes management, drug benefit plan management, pharmacy practice management, and prescription drug reimbursement. His work experience has encompassed activities in practice, academia, professional associations, and state and federal government. He has conducted research and policy analysis in many areas including prescription drug coverage and reimbursement under Medicaid, Medicare, managed care, and commercial third-party programs.
He was appointed to the Prescription Drug Payment Review Commission, which served in an oversight and advisory capacity to Congress for the Medicare Catastrophic Coverage Act outpatient drug program. He has conducted research projects for and consulted with a variety of federal entities including the Centers for Medicare & Medicaid Services (CMS), the US Government Accountability Office (GAO), the Congressional Office of Technology Assessment (OTA), the US Senate Special Committee on Aging, the Food and Drug Administration (FDA), the Department of Justice (DOJ), and the Federal Trade Commission (FTC).
His education, experience, and background provide him with a unique understanding of the complex and technical issues in the challenging and ever-changing pharmaceutical marketplace. He has been an expert witness on pharmaceutical market issues >85 times and an ASPL member since 1975.
Saturday, November 9, 2024
9:05 AM – 10:05 AM MT
